Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Genetic Diversity and Antimicrobial Drug Resistance of Serotype VI Group B Streptococcus, Canada.

Neemuchwala A, Teatero S, Liang L, Martin I, Demzcuk W, McGeer A, Fittipaldi N.

Emerg Infect Dis. 2018 Oct;24(10):1941-1942. doi: 10.3201/eid2410.171711.

2.

In Vitro Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016.

Neemuchwala A, Soares D, Ravirajan V, Marchand-Austin A, Kus JV, Patel SN.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01776-17. doi: 10.1128/AAC.01776-17. Print 2018 Apr.

3.

Genetic evidence for a novel variant of the pilus island 1 backbone protein in group B Streptococcus.

Teatero S, Neemuchwala A, Yang K, Gomes J, Athey TBT, Martin I, Demczuk W, McGeer A, Fittipaldi N.

J Med Microbiol. 2017 Oct;66(10):1409-1415. doi: 10.1099/jmm.0.000588. Epub 2017 Sep 19.

PMID:
28923133
4.

Capsular Switching and Other Large-Scale Recombination Events in Invasive Sequence Type 1 Group B Streptococcus.

Neemuchwala A, Teatero S, Athey TB, McGeer A, Fittipaldi N.

Emerg Infect Dis. 2016 Nov;22(11):1941-1944. doi: 10.3201//eid2211.152064.

5.

Fluoroquinolone Resistance among Clonal Complex 1 Group B Streptococcus Strains.

Neemuchwala A, Teatero S, Patel SN, Fittipaldi N.

Can J Infect Dis Med Microbiol. 2016;2016:6403928. doi: 10.1155/2016/6403928. Epub 2016 Jul 31.

6.
7.

Human metapneumovirus prevalence and molecular epidemiology in respiratory outbreaks in Ontario, Canada.

Neemuchwala A, Duvvuri VR, Marchand-Austin A, Li A, Gubbay JB.

J Med Virol. 2015 Feb;87(2):269-74. doi: 10.1002/jmv.24024. Epub 2014 Aug 5.

PMID:
25091145
8.
9.

Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis.

Jamieson FB, Guthrie JL, Neemuchwala A, Lastovetska O, Melano RG, Mehaffy C.

J Clin Microbiol. 2014 Jun;52(6):2157-62. doi: 10.1128/JCM.00691-14. Epub 2014 Apr 16.

Supplemental Content

Loading ...
Support Center